Skip to Content

Upstaza 2.8 × 10^11 vector genomes / 0.5 mL solution for infusion

Licence status
Authorised: 18/07/2022
Active substances
Eladocagene Exuparvovec
Dosage Form
Solution for infusion
Licence number
EU/1/22/1653/001
Licence holder
PTC Therapeutics International Limited

Licence information

ATC code
A16AB26 eladocagene exuparvovec
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/07/2022